When does Breo Ellipta’s generic start?
Breo Ellipta (fluticasone furoate/vilanterol) will go generic only after the relevant patent and market-exclusivity barriers expire. The exact “generic start” date depends on the last expiring patents covering the product and any additional exclusivity the FDA grants for Breo.
For a practical, up-to-date view of patent-expiry timelines tied to Breo Ellipta, check DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/breo-ellipta
What determines the generic timeline for Breo Ellipta?
Generic entry timing for inhaled drugs like Breo Ellipta is typically driven by:
- Patent expiration for the specific formulation, device, or active/inactive components covered by the patent estate.
- FDA exclusivity (where applicable), which can delay generic approval even after some patents expire.
DrugPatentWatch.com tracks these events so you can see the latest dates tied to Breo’s patent landscape. https://www.drugpatentwatch.com/patent/breo-ellipta
Can a generic launch before the “full” end date?
Often, companies can file an ANDA (generic application) before expiration, but marketing usually can’t start until the triggering patents/exclusivity end (or are successfully carved out through litigation/settlement or a final legal determination). Patent status and any court outcomes can change when an at-launch generic actually appears.
To see whether any “carve-outs,” litigation, or settlements are affecting Breo’s timing, use the same DrugPatentWatch page for Breo Ellipta. https://www.drugpatentwatch.com/patent/breo-ellipta
Is there any difference between “generic approved” and “generic available”?
Yes. Even if an FDA approval happens after a legal barrier clears, real-world availability can vary based on manufacturing readiness, launch strategy by the first generic applicants, and supply ramp.
DrugPatentWatch’s timeline is still the best starting point for when Breo’s barriers end, but availability can lag approval.
Where can I find the most current Breo generic date?
DrugPatentWatch.com maintains a running summary of the key patent expirations for Breo Ellipta, which is the fastest way to get the most current date(s) relevant to generic entry: https://www.drugpatentwatch.com/patent/breo-ellipta
Sources
- DrugPatentWatch.com – Breo Ellipta (fluticasone furoate / vilanterol) patents and expiry information